Covered recipient · General Payments record
STEVEN ALLEN SPARR
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2024
$707.47
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.26 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $96.12 | 4 |
| Alnylam Pharmaceuticals Inc. | $37.33 | 2 |
| EISAI INC. | $30.64 | 1 |
| Neurelis, Inc. | $30.19 | 1 |
| SK Life Science, Inc. | $29.26 | 1 |
| Neurocrine BioSciences, Inc. | $27.76 | 1 |
| Marinus Pharmaceuticals, Inc. | $25.43 | 1 |
| TG THERAPEUTICS, INC. | $23.65 | 1 |
| Amgen Inc. | $20.78 | 1 |
| Grifols USA, LLC | $13.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $19.82 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125857656 | CMS |
| Alnylam Pharmaceuticals Inc. | $17.51 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125857756 | CMS |
| Amgen Inc. | $20.78 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116145120 | CMS |
| Eisai Inc. | $30.64 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110783292 | CMS |
| Grifols USA, LLC | $13.10 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124717908 | CMS |
| Marinus Pharmaceuticals, Inc. | $25.43 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141324476 | CMS |
| Neurelis, Inc. | $30.19 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145655865 | CMS |
| Neurocrine Biosciences, Inc. | $27.76 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150831894 | CMS |
| PFIZER INC. | $26.95 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131420605 | CMS |
| PFIZER INC. | $22.15 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131420601 | CMS |
| PFIZER INC. | $30.52 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131898569 | CMS |
| PFIZER INC. | $16.50 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130879418 | CMS |
| SK Life Science, Inc. | $29.26 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154137716 | CMS |
| TG Therapeutics, Inc. | $23.65 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136885242 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.